STERIS (NYSE:STE) Stock Acquired Rep. April McClain Delaney

Key Points

• Representative April McClain Delaney (D-Maryland) acquired between $1,001 and $15,000 worth of STERIS plc stock on September 18th, according to a filing disclosed on October 6th.
• STERIS reported a quarterly EPS of $2.34, surpassing analysts' expectations, with an 8.8% year-over-year revenue growth to $1.40 billion.
• The company recently increased its quarterly dividend from $0.57 to $0.63 per share, reflecting a 1.0% yield, while maintaining a dividend payout ratio of 38.59%.

Representative April McClain Delaney (D-Maryland) recently bought shares of STERIS plc NYSE: STE. In a filing disclosed on October 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on September 18th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Nasdaq NASDAQ: NDAQ on 9/19/2025.
• Sold $1,001 - $15,000 in shares of Silicon Graphics International NASDAQ: SGI on 9/19/2025.
• Sold $1,001 - $15,000 in shares of Middleby NASDAQ: MIDD on 9/18/2025.
• Purchased $1,001 - $15,000 in shares of Brown & Brown NYSE: BRO on 9/18/2025.
• Purchased $1,001 - $15,000 in shares of Jones Lang LaSalle NYSE: JLL on 9/18/2025.
• Sold $1,001 - $15,000 in shares of Dayforce NYSE: DAY on 9/11/2025.
• Purchased $1,001 - $15,000 in shares of STERIS NYSE: STE on 9/11/2025.
• Purchased $1,001 - $15,000 in shares of BJ's Wholesale Club NYSE: BJ on 8/25/2025.
• Purchased $15,001 - $50,000 in shares of Markel Group NYSE: MKL on 8/21/2025.
• Sold $15,001 - $50,000 in shares of Dayforce NYSE: DAY on 8/19/2025.

STERIS Stock Up 0.4%

Shares of NYSE STE opened at $241.58 on Wednesday. The company has a 50 day simple moving average of $243.63 and a 200 day simple moving average of $235.54. The firm has a market cap of $23.79 billion, a PE ratio of 37.00 and a beta of 1.01. STERIS plc has a 1 year low of $200.98 and a 1 year high of $253.00. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.32 by $0.02. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.36 billion. STERIS had a net margin of 11.61% and a return on equity of 14.17%. The firm's quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $2.03 EPS. On average, research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Thursday, September 4th were issued a $0.63 dividend. This is a boost from STERIS's previous quarterly dividend of $0.57. The ex-dividend date was Thursday, September 4th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS's dividend payout ratio (DPR) is 38.59%.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. KeyCorp raised their price target on shares of STERIS from $277.00 to $288.00 and gave the stock an "overweight" rating in a report on Tuesday, July 22nd. Morgan Stanley raised their price target on shares of STERIS from $276.00 to $295.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Weiss Ratings restated a "buy (b-)" rating on shares of STERIS in a report on Saturday, September 27th. Finally, Wall Street Zen upgraded shares of STERIS from a "buy" rating to a "strong-buy" rating in a report on Sunday, September 14th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and a consensus target price of $273.50.

Institutional Trading of STERIS

Hedge funds have recently modified their holdings of the stock. Allworth Financial LP grew its position in STERIS by 7.3% in the 2nd quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider's stock valued at $159,000 after purchasing an additional 45 shares during the period. Geneos Wealth Management Inc. grew its position in STERIS by 34.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider's stock valued at $42,000 after purchasing an additional 45 shares during the period. Ashton Thomas Private Wealth LLC grew its position in STERIS by 3.5% in the 1st quarter. Ashton Thomas Private Wealth LLC now owns 1,611 shares of the medical equipment provider's stock valued at $365,000 after purchasing an additional 54 shares during the period. Blue Trust Inc. grew its position in STERIS by 16.5% in the 1st quarter. Blue Trust Inc. now owns 395 shares of the medical equipment provider's stock valued at $90,000 after purchasing an additional 56 shares during the period. Finally, Taylor Frigon Capital Management LLC grew its position in STERIS by 1.0% in the 1st quarter. Taylor Frigon Capital Management LLC now owns 6,280 shares of the medical equipment provider's stock valued at $1,423,000 after purchasing an additional 62 shares during the period. Institutional investors own 94.69% of the company's stock.

Insider Buying and Selling at STERIS

In other STERIS news, VP Renato Tamaro sold 3,204 shares of STERIS stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total transaction of $798,564.96. Following the transaction, the vice president directly owned 7,221 shares of the company's stock, valued at $1,799,762.04. The trade was a 30.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Cynthia L. Feldmann sold 3,495 shares of STERIS stock in a transaction on Monday, August 11th. The stock was sold at an average price of $241.56, for a total transaction of $844,252.20. Following the transaction, the director directly owned 705 shares in the company, valued at $170,299.80. This represents a 83.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,709 shares of company stock worth $4,546,940. 1.07% of the stock is owned by company insiders.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.